Compass Therapeutics, Inc. — Director's Dealing 2020

Jun 24, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Compass Therapeutics, Inc. (NONE)
CIK: 0001738021
Period of Report: 2020-06-17

Reporting Person: SQUINTO STEPHEN P (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	34540	Direct

Footnotes

F1: 916 of these shares of common stock underlie unvested restricted stock awards that are subject to a right of repurchase in favor of the issuer, which vest as follows: restricted stock award granted on February 22, 2018, 43.625 shares vest monthly with shares fully vested on February 28, 2022.